| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 9.55e-06 | 22 | 38 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 9.55e-06 | 22 | 38 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 1.73e-04 | 57 | 38 | 3 | GO:0016860 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 1.48e-03 | 30 | 38 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 1.58e-03 | 31 | 38 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 2.13e-03 | 36 | 38 | 2 | GO:0015035 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 3.03e-03 | 43 | 38 | 2 | GO:0015036 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 5.27e-03 | 57 | 38 | 2 | GO:0016667 | |
| GeneOntologyMolecularFunction | isomerase activity | 5.77e-03 | 192 | 38 | 3 | GO:0016853 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 6.80e-03 | 65 | 38 | 2 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 7.01e-03 | 66 | 38 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 7.01e-03 | 66 | 38 | 2 | GO:0001098 | |
| GeneOntologyBiologicalProcess | regulation of hydrogen peroxide catabolic process | 1.98e-05 | 4 | 38 | 2 | GO:2000295 | |
| HumanPheno | Wide nasal bridge | 4.78e-05 | 508 | 12 | 7 | HP:0000431 | |
| HumanPheno | Contracture of the distal interphalangeal joint of the fingers | 7.59e-05 | 6 | 12 | 2 | HP:0009697 | |
| HumanPheno | Dilatation of renal calices | 7.59e-05 | 6 | 12 | 2 | HP:0100581 | |
| HumanPheno | Abnormal renal calyx morphology | 7.59e-05 | 6 | 12 | 2 | HP:0011130 | |
| HumanPheno | Ivory epiphyses of the phalanges of the hand | 7.59e-05 | 6 | 12 | 2 | HP:0010234 | |
| HumanPheno | Sclerosis of finger phalanx | 1.41e-04 | 8 | 12 | 2 | HP:0100899 | |
| HumanPheno | Ivory epiphyses | 1.81e-04 | 9 | 12 | 2 | HP:0010583 | |
| HumanPheno | Branchial fistula | 2.27e-04 | 10 | 12 | 2 | HP:0009795 | |
| MousePheno | zygomatic arch hypoplasia | 4.16e-06 | 2 | 29 | 2 | MP:0030377 | |
| MousePheno | short maxilla | 6.98e-05 | 39 | 29 | 3 | MP:0000097 | |
| MousePheno | skin photosensitivity | 8.67e-05 | 7 | 29 | 2 | MP:0001202 | |
| MousePheno | delayed tooth eruption | 1.85e-04 | 10 | 29 | 2 | MP:0003053 | |
| MousePheno | abnormal maxilla morphology | 2.10e-04 | 144 | 29 | 4 | MP:0000455 | |
| MousePheno | small maxilla | 2.41e-04 | 59 | 29 | 3 | MP:0004540 | |
| MousePheno | abnormal erythrocyte cell number | 2.96e-04 | 457 | 29 | 6 | MP:0001586 | |
| MousePheno | short mandible | 3.07e-04 | 64 | 29 | 3 | MP:0000088 | |
| MousePheno | vertebral fusion | 3.37e-04 | 163 | 29 | 4 | MP:0004609 | |
| MousePheno | abnormal zygomatic arch morphology | 3.72e-04 | 14 | 29 | 2 | MP:0004469 | |
| MousePheno | fused joints | 3.95e-04 | 170 | 29 | 4 | MP:0003189 | |
| MousePheno | abnormal mandible morphology | 4.51e-04 | 176 | 29 | 4 | MP:0000458 | |
| MousePheno | small basisphenoid bone | 4.90e-04 | 16 | 29 | 2 | MP:0004462 | |
| MousePheno | rib fusion | 5.50e-04 | 78 | 29 | 3 | MP:0000154 | |
| Domain | THIOREDOXIN_1 | 1.60e-05 | 25 | 37 | 3 | PS00194 | |
| Domain | LisH | 2.27e-05 | 28 | 37 | 3 | IPR006594 | |
| Domain | LisH | 2.27e-05 | 28 | 37 | 3 | SM00667 | |
| Domain | LISH | 2.27e-05 | 28 | 37 | 3 | PS50896 | |
| Domain | Thioredoxin | 3.10e-05 | 31 | 37 | 3 | PF00085 | |
| Domain | Thioredoxin_domain | 7.24e-05 | 41 | 37 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 8.36e-05 | 43 | 37 | 3 | PS51352 | |
| Domain | Thioredoxin | 2.94e-04 | 13 | 37 | 2 | IPR005746 | |
| Domain | PHD | 4.38e-04 | 75 | 37 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 5.10e-04 | 79 | 37 | 3 | IPR019787 | |
| Domain | PHD | 7.23e-04 | 89 | 37 | 3 | SM00249 | |
| Domain | Znf_PHD | 7.71e-04 | 91 | 37 | 3 | IPR001965 | |
| Domain | ZF_PHD_2 | 8.74e-04 | 95 | 37 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 9.01e-04 | 96 | 37 | 3 | PS01359 | |
| Domain | - | 1.80e-03 | 122 | 37 | 3 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 2.25e-03 | 132 | 37 | 3 | IPR012336 | |
| Domain | Znf_FYVE_PHD | 3.05e-03 | 147 | 37 | 3 | IPR011011 | |
| Domain | ER_TARGET | 3.90e-03 | 47 | 37 | 2 | PS00014 | |
| Domain | Zinc_finger_PHD-type_CS | 7.34e-03 | 65 | 37 | 2 | IPR019786 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.58e-10 | 341 | 40 | 9 | 32971831 | |
| Pubmed | MKI67 PDIA4 NOLC1 SLX4IP KMT2A DIDO1 SIN3A ZZZ3 INTS12 RSL1D1 KIFC1 TRPS1 NPAT | 3.84e-09 | 1429 | 40 | 13 | 35140242 | |
| Pubmed | 4.47e-08 | 653 | 40 | 9 | 22586326 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 9.24e-08 | 954 | 40 | 10 | 36373674 | |
| Pubmed | 9.28e-08 | 503 | 40 | 8 | 16964243 | ||
| Pubmed | 1.25e-07 | 103 | 40 | 5 | 32744500 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.60e-07 | 759 | 40 | 9 | 35915203 | |
| Pubmed | 3.52e-07 | 1103 | 40 | 10 | 34189442 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.91e-07 | 608 | 40 | 8 | 36089195 | |
| Pubmed | 6.10e-07 | 268 | 40 | 6 | 33640491 | ||
| Pubmed | 6.62e-07 | 652 | 40 | 8 | 31180492 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.05e-07 | 934 | 40 | 9 | 33916271 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.50e-06 | 1294 | 40 | 10 | 30804502 | |
| Pubmed | 2.98e-06 | 86 | 40 | 4 | 37253089 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15604408 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27399968 | ||
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 7.93e-06 | 110 | 40 | 4 | 26841866 | |
| Pubmed | 8.84e-06 | 655 | 40 | 7 | 35819319 | ||
| Pubmed | 1.16e-05 | 38 | 40 | 3 | 33283408 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 27050514 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 31130868 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.42e-05 | 989 | 40 | 8 | 36424410 | |
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.73e-05 | 134 | 40 | 4 | 25452129 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.55e-05 | 148 | 40 | 4 | 32538781 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.59e-05 | 774 | 40 | 7 | 15302935 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 23395172 | ||
| Pubmed | The Role of Epithelial Stat3 in Amelogenesis during Mouse Incisor Renewal. | 2.70e-05 | 7 | 40 | 2 | 29550820 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 23133399 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 17612494 | ||
| Pubmed | 4.25e-05 | 339 | 40 | 5 | 30415952 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 4.31e-05 | 1155 | 40 | 8 | 20360068 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 15199122 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.01e-05 | 351 | 40 | 5 | 38297188 | |
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 20153263 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 18156176 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 24788519 | ||
| Pubmed | RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma. | 5.85e-05 | 183 | 40 | 4 | 28186131 | |
| Pubmed | Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. | 7.05e-05 | 11 | 40 | 2 | 18082152 | |
| Pubmed | HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells. | 7.31e-05 | 70 | 40 | 3 | 17342744 | |
| Pubmed | 9.96e-05 | 210 | 40 | 4 | 16565220 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.09e-04 | 1318 | 40 | 8 | 30463901 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 1.13e-04 | 217 | 40 | 4 | 31685992 | |
| Pubmed | Cell-fate determination by ubiquitin-dependent regulation of translation. | 1.16e-04 | 14 | 40 | 2 | 26399832 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.34e-04 | 695 | 40 | 6 | 23602568 | |
| Pubmed | Multisite dependency of an E3 ligase controls monoubiquitylation-dependent cell fate decisions. | 1.34e-04 | 15 | 40 | 2 | 29999490 | |
| Pubmed | 1.34e-04 | 15 | 40 | 2 | 34487921 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.50e-04 | 1024 | 40 | 7 | 24711643 | |
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 23245351 | ||
| Pubmed | 1.53e-04 | 16 | 40 | 2 | 26116663 | ||
| Pubmed | Chondroitin sulfate synthase 1 (Chsy1) is required for bone development and digit patterning. | 1.73e-04 | 17 | 40 | 2 | 22280990 | |
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 32245798 | ||
| Pubmed | 1.73e-04 | 17 | 40 | 2 | 27806305 | ||
| Pubmed | 1.80e-04 | 245 | 40 | 4 | 21182205 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.86e-04 | 1425 | 40 | 8 | 30948266 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 27578791 | ||
| Pubmed | 2.03e-04 | 253 | 40 | 4 | 29911972 | ||
| Pubmed | 2.13e-04 | 1084 | 40 | 7 | 11544199 | ||
| Pubmed | 2.18e-04 | 19 | 40 | 2 | 31084574 | ||
| Pubmed | An endoplasmic reticulum stress regulator, Tmbim6, modulates secretory stage of mice molar. | 2.42e-04 | 20 | 40 | 2 | 30963569 | |
| Pubmed | 2.47e-04 | 494 | 40 | 5 | 26831064 | ||
| Pubmed | 2.54e-04 | 1116 | 40 | 7 | 31753913 | ||
| Pubmed | 2.60e-04 | 1497 | 40 | 8 | 31527615 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.64e-04 | 271 | 40 | 4 | 32433965 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 2.64e-04 | 271 | 40 | 4 | 25737280 | |
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 12453419 | ||
| Pubmed | ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. | 2.67e-04 | 21 | 40 | 2 | 30985297 | |
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 24483844 | ||
| Pubmed | Sin3a regulates epithelial progenitor cell fate during lung development. | 2.67e-04 | 21 | 40 | 2 | 28619823 | |
| Pubmed | 2.76e-04 | 506 | 40 | 5 | 30890647 | ||
| Pubmed | 3.03e-04 | 281 | 40 | 4 | 24163370 | ||
| Pubmed | Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis. | 3.21e-04 | 23 | 40 | 2 | 32597834 | |
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 3.80e-04 | 25 | 40 | 2 | 15385968 | |
| Pubmed | ZNF750 Regulates Skin Barrier Function by Driving Cornified Envelope and Lipid Processing Pathways. | 3.80e-04 | 25 | 40 | 2 | 37660780 | |
| Pubmed | 3.80e-04 | 25 | 40 | 2 | 17684299 | ||
| Pubmed | 3.97e-04 | 124 | 40 | 3 | 20850016 | ||
| Pubmed | 4.01e-04 | 549 | 40 | 5 | 38280479 | ||
| Pubmed | 4.45e-04 | 27 | 40 | 2 | 31505254 | ||
| Pubmed | 5.09e-04 | 135 | 40 | 3 | 31405213 | ||
| Pubmed | 5.13e-04 | 29 | 40 | 2 | 17577209 | ||
| Pubmed | MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity. | 5.13e-04 | 29 | 40 | 2 | 30093671 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 5.49e-04 | 329 | 40 | 4 | 34316702 | |
| Pubmed | Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. | 5.87e-04 | 31 | 40 | 2 | 17765678 | |
| Pubmed | 5.92e-04 | 1285 | 40 | 7 | 35914814 | ||
| Pubmed | 6.05e-04 | 601 | 40 | 5 | 33658012 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 6.23e-04 | 605 | 40 | 5 | 28977666 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 6.26e-04 | 32 | 40 | 2 | 15848144 | |
| Pubmed | 6.26e-04 | 32 | 40 | 2 | 9611252 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | 6.56e-04 | 345 | 40 | 4 | 15164054 | |
| Pubmed | Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth. | 6.66e-04 | 33 | 40 | 2 | 26952977 | |
| Pubmed | 6.78e-04 | 149 | 40 | 3 | 25184681 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 7.06e-04 | 949 | 40 | 6 | 36574265 | |
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 20189936 | ||
| Pubmed | SLX4IP acts with SLX4 and XPF-ERCC1 to promote interstrand crosslink repair. | 7.07e-04 | 34 | 40 | 2 | 31495888 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 7.45e-04 | 357 | 40 | 4 | 37059091 | |
| Pubmed | 7.69e-04 | 634 | 40 | 5 | 34591612 | ||
| Pubmed | 7.74e-04 | 156 | 40 | 3 | 37108203 | ||
| Pubmed | 7.74e-04 | 156 | 40 | 3 | 22952844 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 7.89e-04 | 157 | 40 | 3 | 30686591 | |
| Pubmed | 8.31e-04 | 645 | 40 | 5 | 25281560 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 8.53e-04 | 1367 | 40 | 7 | 32687490 | |
| Interaction | FAM90A26 interactions | 3.65e-06 | 2 | 39 | 2 | int:FAM90A26 | |
| Interaction | ZBTB38 interactions | 8.51e-06 | 145 | 39 | 5 | int:ZBTB38 | |
| Interaction | SIRT7 interactions | 9.50e-06 | 744 | 39 | 9 | int:SIRT7 | |
| Interaction | HECTD1 interactions | 1.28e-05 | 984 | 39 | 10 | int:HECTD1 | |
| Interaction | SMC5 interactions | 1.47e-05 | 1000 | 39 | 10 | int:SMC5 | |
| Interaction | MEN1 interactions | 1.89e-05 | 1029 | 39 | 10 | int:MEN1 | |
| Interaction | H2BC5 interactions | 3.88e-05 | 331 | 39 | 6 | int:H2BC5 | |
| Interaction | UHRF2 interactions | 4.01e-05 | 200 | 39 | 5 | int:UHRF2 | |
| Interaction | H3C3 interactions | 4.02e-05 | 495 | 39 | 7 | int:H3C3 | |
| Interaction | H2BC13 interactions | 5.05e-05 | 210 | 39 | 5 | int:H2BC13 | |
| Interaction | CSNK2A2 interactions | 5.77e-05 | 718 | 39 | 8 | int:CSNK2A2 | |
| Interaction | SNX29 interactions | 7.30e-05 | 42 | 39 | 3 | int:SNX29 | |
| Interaction | H3-3A interactions | 7.76e-05 | 749 | 39 | 8 | int:H3-3A | |
| Interaction | TERF2IP interactions | 8.00e-05 | 552 | 39 | 7 | int:TERF2IP | |
| Interaction | NAA40 interactions | 8.17e-05 | 978 | 39 | 9 | int:NAA40 | |
| Interaction | CEBPA interactions | 9.54e-05 | 1245 | 39 | 10 | int:CEBPA | |
| Interaction | NOP56 interactions | 9.77e-05 | 570 | 39 | 7 | int:NOP56 | |
| Interaction | APEX1 interactions | PDIA4 NOLC1 KMT2A DIDO1 OCEL1 SIN3A EIF4G3 TCOF1 RSL1D1 TRPS1 | 1.13e-04 | 1271 | 39 | 10 | int:APEX1 |
| Interaction | CXXC1 interactions | 1.21e-04 | 132 | 39 | 4 | int:CXXC1 | |
| Interaction | KLF16 interactions | 1.54e-04 | 425 | 39 | 6 | int:KLF16 | |
| Interaction | NUP43 interactions | 1.73e-04 | 625 | 39 | 7 | int:NUP43 | |
| Interaction | ARL4D interactions | 1.79e-04 | 146 | 39 | 4 | int:ARL4D | |
| Interaction | CUL7 interactions | 1.79e-04 | 845 | 39 | 8 | int:CUL7 | |
| Interaction | NSD2 interactions | 1.89e-04 | 278 | 39 | 5 | int:NSD2 | |
| Interaction | CYP4V2 interactions | 1.99e-04 | 11 | 39 | 2 | int:CYP4V2 | |
| Interaction | HDAC1 interactions | 2.11e-04 | 1108 | 39 | 9 | int:HDAC1 | |
| Interaction | PI4KB interactions | 2.12e-04 | 60 | 39 | 3 | int:PI4KB | |
| Interaction | RBBP5 interactions | 2.19e-04 | 287 | 39 | 5 | int:RBBP5 | |
| Interaction | YY1 interactions | 2.20e-04 | 454 | 39 | 6 | int:YY1 | |
| Interaction | CAVIN1 interactions | 2.37e-04 | 292 | 39 | 5 | int:CAVIN1 | |
| Interaction | DNAH3 interactions | 2.38e-04 | 12 | 39 | 2 | int:DNAH3 | |
| Interaction | HCFC1 interactions | 2.41e-04 | 293 | 39 | 5 | int:HCFC1 | |
| Interaction | RNF113A interactions | 3.22e-04 | 692 | 39 | 7 | int:RNF113A | |
| Interaction | BRD3 interactions | 3.45e-04 | 494 | 39 | 6 | int:BRD3 | |
| Interaction | RCOR1 interactions | 3.45e-04 | 494 | 39 | 6 | int:RCOR1 | |
| Interaction | CHD4 interactions | 3.63e-04 | 938 | 39 | 8 | int:CHD4 | |
| Interaction | SRPK2 interactions | 3.99e-04 | 717 | 39 | 7 | int:SRPK2 | |
| GeneFamily | PHD finger proteins | 1.49e-04 | 90 | 21 | 3 | 88 | |
| GeneFamily | Protein disulfide isomerases | 2.66e-04 | 21 | 21 | 2 | 692 | |
| GeneFamily | Fibronectin type III domain containing | 1.46e-02 | 160 | 21 | 2 | 555 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | MYBPH MKI67 NOLC1 DIDO1 ZZZ3 CSF2RB TCOF1 RSL1D1 VPS4B KIFC1 NPAT | 2.94e-06 | 1394 | 38 | 11 | M9585 |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.06e-06 | 130 | 39 | 4 | 169d88bffd7cd813a484d809defa638ceaca4bcb | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 153 | 39 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-new-cluster|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 174 | 39 | 4 | 718e14d9a4264456459bec4c062c94c3a848d43a | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 174 | 39 | 4 | 02ab165b064acb91f2d3f59cc5be195899d61a83 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 175 | 39 | 4 | 61fdafba120fbda063d4dc05263d6f8d1dcab1e1 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 175 | 39 | 4 | 8de8031fdf2af187642833feb80caa64932897cf | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-05 | 176 | 39 | 4 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | 2.21e-05 | 189 | 39 | 4 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.30e-05 | 191 | 39 | 4 | b23fdcd3090df9f58310b4dc8f7dc0c6d6b33226 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.35e-05 | 192 | 39 | 4 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-05 | 195 | 39 | 4 | c96755d2eb98112b703b5dbee9c88730ace7dcbf | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, condition lineage and cell class | 2.65e-05 | 198 | 39 | 4 | 614055c11d1dd2f3f2b8783ec35a8f4570cad161 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.71e-05 | 199 | 39 | 4 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.86e-04 | 147 | 39 | 3 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.92e-04 | 148 | 39 | 3 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 3.47e-04 | 157 | 39 | 3 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | E15.5-Hematopoietic|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.47e-04 | 157 | 39 | 3 | 6315aef4b9bf673069d43a730d4e940011509ac1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 158 | 39 | 3 | 1e7bf5f51a6582026b844095fc11434430a83dab | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 4.09e-04 | 166 | 39 | 3 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.09e-04 | 166 | 39 | 3 | 004ab6a1425d812c7ce572205875fd702d4a9659 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-04 | 167 | 39 | 3 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-04 | 167 | 39 | 3 | 650de8cd5df070639b8aa292aacead739cfdb02c | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.23e-04 | 168 | 39 | 3 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.23e-04 | 168 | 39 | 3 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Developing_Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.38e-04 | 170 | 39 | 3 | cfd7f29805b7c51666b0eaf269c36c96b8765a1a | |
| ToppCell | 367C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 4.38e-04 | 170 | 39 | 3 | fbb7019c6fba87326702b51f6819ea1af5f3a9b7 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | 95e87987a2332fa646849fb0de785f1e0b8a07dd | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | 36657e277aad75c4f157c1726c48e09b5836cf37 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 31c5710fd7ebb221e703545595f5ec0ee3a32bcf | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 6004327045f03d832fdabe6cb2f8b1b1db57789a | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-04 | 173 | 39 | 3 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | 4.69e-04 | 174 | 39 | 3 | e8d2aa9505817aac3fe068080774d19458f07b01 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.77e-04 | 175 | 39 | 3 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-04 | 175 | 39 | 3 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | T_cells-Tph_and_Tfh|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.85e-04 | 176 | 39 | 3 | 56c055488e34605d32562571a2fee621b47c9441 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.85e-04 | 176 | 39 | 3 | 98814f0a67411b2f7b25dc489b2aadb77f45a853 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.93e-04 | 177 | 39 | 3 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.93e-04 | 177 | 39 | 3 | d2c1f46913ac00bbc0bb9320d5652edc01b34179 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.93e-04 | 177 | 39 | 3 | 65e090aad0ffb737ce034e25bd5b12a0b1dd9684 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.01e-04 | 178 | 39 | 3 | 40a280c1e35963dd45d1809a3e85b568344dd1f5 | |
| ToppCell | normal-na-Lymphocytic_B-plasmablast|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.01e-04 | 178 | 39 | 3 | 4fe87c713770173336177e3488f7b4a3be54f71b | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 178 | 39 | 3 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 178 | 39 | 3 | be8af4d85b8835a85a168639c37857dcaa6b00bf | |
| ToppCell | Healthy_donor-Plasmablast|Healthy_donor / disease group, cell group and cell class (v2) | 5.01e-04 | 178 | 39 | 3 | 388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 178 | 39 | 3 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.09e-04 | 179 | 39 | 3 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 5.09e-04 | 179 | 39 | 3 | 7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.09e-04 | 179 | 39 | 3 | ba7744b903abfc28b39a00472661f152e9ae39fd | |
| ToppCell | CV-Healthy-2|CV / Virus stimulation, Condition and Cluster | 5.18e-04 | 180 | 39 | 3 | e182e5c495dd82d4fcbf1a920086c70b064801f3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | ce2fc270f9d9110c2544083f61936b0b7d3b7eb3 | |
| ToppCell | HSPCs-Mono_prog.|HSPCs / Lineage and Cell class | 5.26e-04 | 181 | 39 | 3 | a188f0d22426d8723ba394d94d20431afa6722a7 | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.26e-04 | 181 | 39 | 3 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 181 | 39 | 3 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 81c394959414173016426961478f670cd822f8b3 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | a00abff41c12b71d5860c494b8c722d649fd5f36 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 41a7543c8b703441ff6ac2307faffe5f798b2c41 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.35e-04 | 182 | 39 | 3 | 626aabfd9ac662c1d189f7c4b660482914d9e669 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.35e-04 | 182 | 39 | 3 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-04 | 182 | 39 | 3 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | 5.43e-04 | 183 | 39 | 3 | 2477183a290b2c45b6fa091ed76969a3826fe3d9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-04 | 183 | 39 | 3 | c5e90577b57a86c06afdf89d4b519b3694f813f9 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 184 | 39 | 3 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 184 | 39 | 3 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-04 | 185 | 39 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-04 | 185 | 39 | 3 | ff598af88c7f9d7224cc4ed96b1c3463ef76b550 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.61e-04 | 185 | 39 | 3 | a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.61e-04 | 185 | 39 | 3 | a4792d8df52d80951fb9d022c49821df52100e67 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | mild_COVID-19-Plasmablast|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.69e-04 | 186 | 39 | 3 | a639d2183b85b1be6e6da2b2e112aec5149d5bcd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 186 | 39 | 3 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.78e-04 | 187 | 39 | 3 | 88d20f150df61ef0e3ee0c3e9895b094920c4b09 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | f491ec986dd44e2dabdf4a75c3101e3b6c921872 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.78e-04 | 187 | 39 | 3 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.78e-04 | 187 | 39 | 3 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 5.78e-04 | 187 | 39 | 3 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.78e-04 | 187 | 39 | 3 | 158c2c003fd225ba61793fb06eece232fb063d05 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-04 | 187 | 39 | 3 | 96dc5dc4dbc1b33c2e66666e9027cfbf7972090b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.78e-04 | 187 | 39 | 3 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | control-Lymphocytic-Plasmablast|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.78e-04 | 187 | 39 | 3 | 94a44b31ce9fe6fb4758769018fb746e93c8f043 | |
| ToppCell | mild_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 5.87e-04 | 188 | 39 | 3 | 9a5ba6abdc307402301dae25db2a5f3e0d576417 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-04 | 188 | 39 | 3 | 6844cebca177fdf38b21a40d606230a033717a3a | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 1ff13434dfe60c8184d5f33041e325eca41392bc | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.87e-04 | 188 | 39 | 3 | 599195338070ac6b79bd114609d9e10cac4f1df4 | |
| ToppCell | severe_COVID-19-Plasmablast|World / disease group, cell group and cell class (v2) | 5.87e-04 | 188 | 39 | 3 | 25ca19af4ac419a0f5026a6ccbd8b554b268a6f3 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | b2472a294b25fc2f0da7f18519fdcb9ca166c6f0 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | 9fc3f17045606f1fe29d296326da9482db58433b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 5.87e-04 | 188 | 39 | 3 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.87e-04 | 188 | 39 | 3 | ecba5d06cbf3254448255a2aeefffe711f43310e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.87e-04 | 188 | 39 | 3 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-04 | 188 | 39 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 2.29e-05 | 6 | 37 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 4.33e-05 | 156 | 37 | 4 | C0376634 | |
| Disease | Colorectal Carcinoma | 2.20e-04 | 702 | 37 | 6 | C0009402 | |
| Disease | Severe Congenital Microcephaly | 6.95e-04 | 31 | 37 | 2 | C3853041 | |
| Disease | Microlissencephaly | 7.88e-04 | 33 | 37 | 2 | C1956147 | |
| Disease | lung cancer (is_marker_for) | 1.10e-03 | 39 | 37 | 2 | DOID:1324 (is_marker_for) | |
| Disease | body surface area | 1.18e-03 | 643 | 37 | 5 | EFO_0022196 | |
| Disease | lean body mass | 1.27e-03 | 379 | 37 | 4 | EFO_0004995 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.87e-03 | 713 | 37 | 5 | EFO_0005689 | |
| Disease | leukemia | 2.18e-03 | 55 | 37 | 2 | C0023418 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPVQQPEKRKQKPSP | 506 | Q6L9W6 | |
| TPFGTQIPQKQEKKP | 246 | Q03468 | |
| TQPPKKAVEKQQPVE | 306 | Q14978 | |
| AIAKKLPKNEPQNPG | 176 | P20339 | |
| QPQPGPHKAKTKKIV | 101 | Q9H607 | |
| QKTQKPPQKPAPAVV | 221 | Q96CB8 | |
| PVPPKSQKAQGLRNK | 986 | Q14207 | |
| TPFGTQIPQKQEKKP | 246 | P0DP91 | |
| PVKNQGPVVPESVKN | 701 | Q96JE9 | |
| KKTPKSPVGVQPILN | 321 | P00738 | |
| KIQQPSKNPSVPMQK | 76 | O60551 | |
| PVKKQPQKPRGGQRV | 921 | O60524 | |
| KPQVEANPGPLNKDK | 86 | Q86YD7 | |
| TGLKNQKPVPAVPVQ | 101 | Q9BW19 | |
| GKGPVFVKPKNTQPV | 751 | Q14766 | |
| QDIKKPVQQPAKQAP | 46 | Q9UQV4 | |
| NLPGSKRQPQTPKEK | 2416 | P46013 | |
| QVKKPPGQAVPQVPV | 856 | P32927 | |
| AVGKQPAPRNLVPKK | 556 | Q9BTC0 | |
| QSKQKKVAPRPSIPV | 1341 | Q03164 | |
| ETQKPNQTQSKKPPQ | 121 | Q9NRM1 | |
| KVQQQKAFPGTVPIP | 6306 | Q8NDH2 | |
| AKPQVQPQKRKPKTG | 56 | P22830 | |
| VPTQQQPPPAKREKK | 126 | O43432 | |
| PKNIPQGAPVKQKTV | 441 | Q13423 | |
| VVVVVAKPKGPPVQK | 561 | Q8N807 | |
| KGPPQKAGPVAVQVK | 586 | Q13428 | |
| KPQVEANPGPLNKDK | 86 | D6RGX4 | |
| GTVKKPQLNNKPQRP | 406 | Q96ST3 | |
| TVNLQIPFQGKPKPQ | 191 | Q13203 | |
| KPVIKSQPVPKNNKG | 511 | P13667 | |
| SQPVPKNNKGPVKVV | 516 | P13667 | |
| SQPKVSTPVVKQGPV | 476 | Q9BTA9 | |
| PCPKQSPRVAKTQQK | 281 | Q5VYV7 | |
| KKAQKPVKEGQPSPA | 81 | O75351 | |
| KAPPNVKNEGPLNVV | 1186 | Q9UHF7 | |
| PQLVPIGKKTPANEK | 366 | O76021 | |
| KKQCPPKGTIIPAQQ | 51 | Q96PI1 | |
| PIQPKLGNIPKASVK | 156 | Q86VQ3 | |
| PIQPKLGNIPKASVK | 261 | Q86VQ3 | |
| KPQVEANPGPLNKDK | 86 | Q658T7 | |
| KKRPEPVPIQKGNNN | 51 | Q8IYH5 | |
| QGVNNVKPPAVAPEK | 101 | Q8NC26 |